Showing results (1281-1290 of 14,091) with videos related to

Sort By:
Pageof 1,410
Gynecologic Oncology|August 25, 2009
BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamideMarie-Claude Beauchamp, Ariane Knafo, Amber Yasmeen, et al.
Gynecologic Oncology|August 12, 2009
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodesNadeem R Abu-Rustum, Jacob D Gomez, Kaled M Alektiar, et al.
Gynecologic Oncology|August 12, 2009
High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and olderMona Bansal, R Marshall Austin, Chengquan Zhao
Gynecologic Oncology|August 21, 2009
Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006Nana E Tchabo, Susan McCloskey, Terry L Mashtare, et al.
Gynecologic Oncology|October 27, 2009
AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinomaYoram Cohen, Bruria Shalmon, Jacob Korach, et al.
Gynecologic Oncology|February 16, 2010
Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 yearKristine Ansenberger, Cassandra Richards, Yan Zhuge, et al.
Gynecologic Oncology|December 27, 2005
Feasibility study comparing docetaxel-cisplatin versus docetaxel-carboplatin as first-line chemotherapy for ovarian cancerYukihisa Minagawa, Junzo Kigawa, Yasunobu Kanamori, et al.
Gynecologic Oncology|December 27, 2005
Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancerT Le, L Hopkins, K A Baines, et al.
Gynecologic Oncology|December 27, 2005
Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarraySang-Soo Seo, Yong-Sang Song, Jae-Weon Kim, et al.
Gynecologic Oncology|December 27, 2005
Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group studyRichard P McQuellon, Howard T Thaler, David Cella, et al.
Pageof 1,410